drugset / Trial / NCT00958412

Study Evaluating the Safety and Efficacy of Proellex® in the Treatment of Endometriosis-extension Study

NCT00958412

Phase 2 Terminated 18 enrolled Repros Therapeutics Inc.
NaSingle-groupOpen-labelTreatment

Summary

ZPE-201 Extension of treatment

Timeline

Start
2009-02-28
Primary completion
2009-08-31
Completion
2009-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Telapristone Acetate Other / unclassified 25 mg

Indications